Author

Li Gan

Weill Cornell MedicineORCID 0000-0002-9250-7807Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Li Gan7 papers · Weill Cornell Medicine

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Balaji KrishnamacharyiD· 1 shared Benjamin LiechtyiD· 1 shared Daphne Zhu· 1 shared H LI· 1 shared Hao CheniD· 1 shared Jingjie ZhuiD· 1 shared Jorge J. PalopiD· 1 shared Junfang WuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Balaji KrishnamacharyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsy

Yige Huang, Li Fan, Man Ying Wong, Zhuofan Lei, Balaji Krishnamachary, Daphne Zhu, Mika P. Cadiz, Ravi Kumar Nagiri, Pearly Ye, Kendra Norman, Maitreyee Bhagwat, Young Jae Lee, H LI, Jingjie Zhu, Sadaf Amin, , Li Gan

This study identifies cGAS-mediated IFN-I signaling as a driver of disease progression in drug-refractory epilepsy, showing that targeting cGAS reduces epileptic phenotypes and inflammation.

bioRxiv · Feb 2, 2026 · PreprintNeuroscience